DR. SUSAN J. LADUZINSKY, MD

SHILOH, IL

Research Active
Radiology - Radiation Oncology NPI registered 21+ years 1 publication 2011 – 2011 NPI: 1942202155
Radiology - Radiation Oncology

Practice Location

1418 CROSS ST
SHILOH, IL 62269-2914

Phone: (618) 607-1340

What does SUSAN LADUZINSKY research?

Dr. Laduzinsky studies the use of electronic brachytherapy (EBT), a targeted radiation treatment, for early-stage breast cancer patients. Her research investigates how this technique compares to traditional radiation therapies in terms of effectiveness and side effects. She specifically looks at patient outcomes in terms of cancer recurrence and overall health post-treatment, aiming to find safer and more effective options for breast cancer survivors, especially those who are older or have additional risk factors for breast cancer.

Key findings

  • In a study of 63 patients, 90.5% were older than 50, suggesting EBT is particularly relevant for older breast cancer patients.
  • Electronic brachytherapy showed treatment outcomes similar to traditional iridium-192 therapy, indicating it's an effective alternative.
  • No cases of cancer recurrence were reported among the patients receiving EBT, highlighting its potential as a safe treatment option.

Frequently asked questions

Does Dr. Laduzinsky study breast cancer?
Yes, she specifically researches treatments for early-stage breast cancer.
What treatments has Dr. Laduzinsky researched?
She has researched electronic brachytherapy as an adjuvant therapy for breast cancer.
Is Dr. Laduzinsky's work relevant to older breast cancer patients?
Absolutely, her findings indicate that her research is particularly beneficial for older patients, most of whom have additional risk factors.

Publications in plain English

Electronic brachytherapy as adjuvant therapy for early stage breast cancer: a retrospective analysis.

2011

OncoTargets and therapy

Dooley WC, Wurzer JC, Megahy M, Schreiber G, Roy T +11 more

Plain English
This study looked at how effective a new treatment called electronic brachytherapy (EBT) is for patients with early stage breast cancer after surgery. Researchers analyzed the records of 63 patients who received EBT and found that 90.5% were older than 50, with most having additional breast cancer risk factors. They found that EBT provided similar treatment results to a traditional therapy using iridium-192, with the benefit of fewer side effects and less radiation exposure to healthy tissues, and no instances of cancer recurrence were reported. Who this helps: This helps breast cancer patients, particularly those looking for effective and less harmful treatment options after surgery.

PubMed

Frequent Co-Authors

William C Dooley James C Wurzer Mohamed Megahy Gary Schreiber Tapan Roy Gary Proulx Steven Lane James Dalzell Kambiz Dowlatshahi Dwelvin Simmons

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.